Jason Slakter, MDEnriched profile
Clinical Professor of Ophthalmology, NYU Grossman School of Medicine; Founder and Medical Director, Vitreous Retina Macula Consultants of New York (VRMNY) · NYU Grossman School of Medicine (Department of Ophthalmology) / Vitreous Retina Macula Consultants of New York (VRMNY)
Overview
Updated 14 Jul 2026
Jason S. Slakter, MD, is Clinical Professor of Ophthalmology, NYU Grossman School of Medicine. The public record shows 192 publications with 16,592 citations (h-index 57), centered on Macular Degeneration (AMD). It also documents an investigator role on 7 registered clinical trials, industry payments reported by 9 companies.
- Top research focus: Macular Degeneration (AMD)
- 7 registered trials on ClinicalTrials.gov
- Open Payments reporting from 9 companies
Generated from the cited public record · current as of 14 Jul 2026. Every fact links its source below.
Indications focusfrom trials led + research topics
Research focusOpenAlex concept fingerprint
Drugs & moleculesacross trials, industry payments and publications
Works withtrial sponsors and companies reporting payments
Scholarshipindexed output and impact (OpenAlex)
View publications ↓Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industrytrials, payments and federal funding
Federally funded research awards.
Clinical trials
Updated 14 Jul 2026
Listed as an investigator on 7 registered studies on ClinicalTrials.gov. The most recent:
- Study of Efalizumab Combined With Intravitreal Ranibizumab in the Treatment of Age-Related Macular Degeneration
Sponsor: Vitreous -Retina- Macula Consultants of New York
InvestigatorPhase 1WithdrawnNCT00726466 - Safety of Intravitreal POT-4 Therapy for Patients With Neovascular Age-Related Macular Degeneration (AMD)
Sponsor: Potentia Pharmaceuticals, Inc.
InvestigatorPhase 1CompletedNCT00473928 - Bevacizumab in Combination With Verteporfin Reduced and Standard Fluence in the Treatment of Hemorrhaged Lesions in Neovascular AMD
Sponsor: Vitreous -Retina- Macula Consultants of New York
InvestigatorPhase 1TerminatedNCT00403442
Industry payments
Updated 14 Jul 2026
9 companies reported payments to CMS in program years 2021–2025. These are public disclosures, not judgments. The latest:
- Apellis Pharmaceuticals, Inc.Program year20251 payment
- ABBVIE INC.Program year20252 payments
- Apellis Pharmaceuticals, Inc.Program year20244 payments
NIH funding
We didn't find any NIH-funded research awards for this person in NIH RePORTER. Why? →
Publications
None on file yet. We only list publications we can confidently match to this person. Why? →
Contact
An office address from a public listing. This research profile has no federal registry record to draw from.
Office address
950 Third Avenue, 3rd Floor, New York, NY 10022
Background & recognition
Updated 14 Jul 2026
Credentials, appointments and honors, newest first, each linked to the public source it came from.
Educationdegrees and training on record
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →nyulangone.org ↗
- Fellowship in Vitreoretinal Surgery/Medical and Surgical Retinal Diseases
Manhattan Eye, Ear & Throat Hospital
1988provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →nyulangone.org ↗ - provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →nyulangone.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →nyulangone.org ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →vrmny.com ↗
Editorial & leadership rolesjournal and society appointments
- Founding Editor-in-Chief
Retinal Physician journal
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →vrmny.com ↗ - Member
American Ophthalmological Society
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →vrmny.com ↗ - Member
Retina Society
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →vrmny.com ↗
Awards & honorshonors on the public record
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vrmny.com ↗
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →vrmny.com ↗
- provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →vrmny.com ↗
Secondary affiliationsappointments beyond the home institution
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →globenewswire.com ↗
- Former Assistant Clinical Professor of Ophthalmology
College of Physicians and Surgeons, Columbia University
2001provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →ois.net ↗ - Founder and Director
Digital Angiography Reading Center (DARC), over 1,000 certified clinical sites in 44+ countries for retinal clinical trial imaging
Media & interviewspress, podcasts and appearances
- verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →prnewswire.com ↗
- Podcast guest: Empowered Patient Podcast
"Advances in Treating Wet Age-Related Macular Degeneration with Dr. Jason Slakter"
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →empoweredpatientradio.com ↗
Every item links to where we found it. verified means we've confirmed it in more than one place; provisional means we found it and are still confirming.
Online presence
Updated 14 Jul 2026
This person's own public accounts first, then places where others mention them. Two different things, listed separately.
Owned accountspublic accounts run by this person
- LinkedIn
linkedin.com/in/jason-s-slakter-md-32260715
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗ - LinkedIn
linkedin.com/in/jason-slakter-005a64102
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →linkedin.com ↗
Mentions by otherswhere others cite or feature them
- Instagram
instagram.com/vrm.ny/p/Cs4WJ_Fxr7y
verifiedCorroborated by findmyKOL. We matched this record across two or more independent public sources (or a verified ORCID / NPI identifier bridge) before attributing it to this person.How we verify →instagram.com ↗ - Other
empoweredpatientradio.com/podcast/advances-in-treating-wet-age-related-macular-degeneration-with-dr-jason-slakter-ohr-pharmaceutical
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →empoweredpatientradio.com ↗ - YouTube
youtube.com/watch
provisionalFound in a cited public source but not yet independently corroborated. Published as a labeled candidate and queued for verification.How we verify →youtube.com ↗
We list an account only when the public record ties it to this person. verified means we've confirmed the match in more than one place; provisional means it looks right but we're still confirming.
Similar KOLs
Other experts from the same institution or the same specialty.
No other directory profiles share this specialty yet.